Trademark: 97588036
Word
NCYTE
Status Date
Monday, September 30, 2024
Filing Date
Monday, September 12, 2022
Abandoned Date
Monday, September 30, 2024
42 Pre-clinical scientific research and trials for others in the nature of creating human cell models from stem cells for use in drug efficacy testing in the field of biomedical research, none of the foregoing for the treatment of viral, hematological, oncological, auto-immune, inflammatory, metabolic, and dermatological disorders
Sep 28, 2022
New Application Office Supplied Data Entered
Sep 15, 2022
New Application Entered
Dec 19, 2022
Assigned To Examiner
Jan 6, 2023
Non-Final Action Written
Jan 6, 2023
Non-Final Action E-Mailed
Jan 6, 2023
Notification Of Non-Final Action E-Mailed
Apr 6, 2023
Teas Response To Office Action Received
Apr 6, 2023
Correspondence Received In Law Office
Apr 6, 2023
Teas/Email Correspondence Entered
May 12, 2023
Final Refusal Written
May 12, 2023
Final Refusal E-Mailed
May 12, 2023
Notification Of Final Refusal Emailed
Aug 14, 2023
Application Extension To Response Period - Received
Aug 14, 2023
Application Extension Granted/Receipt Provided
Nov 13, 2023
Teas Request For Reconsideration Received
Nov 13, 2023
Exparte Appeal Received At Ttab
Nov 13, 2023
Ex Parte Appeal-Instituted
Nov 13, 2023
Jurisdiction Restored To Examining Attorney
Mar 5, 2024
Assigned To Lie
Mar 5, 2024
Correspondence Received In Law Office
Mar 5, 2024
Teas/Email Correspondence Entered
Mar 5, 2024
Subsequent Final Refusal Written
Mar 5, 2024
Subsequent Final Emailed
Mar 5, 2024
Notification Of Subsequent Final Emailed
Apr 8, 2024
Notification Of Subsequent Final Emailed
Apr 8, 2024
Subsequent Final Refusal Written
May 7, 2024
Correspondence Received In Law Office
May 7, 2024
Teas Request For Reconsideration Received
Jun 7, 2024
Action Denying Req For Recon E-Mailed
Apr 8, 2024
Subsequent Final Emailed
May 7, 2024
Teas/Email Correspondence Entered
Jun 7, 2024
Action Continuing Final - Completed
Jun 7, 2024
Notification Of Action Denying Req For Recon E-Mailed
Aug 20, 2024
Exparte Appeal Dismissed - Failure To File Brief
Sep 30, 2024
Abandonment - After Ex Parte Appeal
Sep 30, 2024
Exparte Appeal Terminated
Oct 2, 2024
Abandonment Notice Mailed - After Ex Parte Appeal
Trademark Alertz updated from USPTO on 2030-01-24
